Dr Reddy enters dermatology topical steroid market

New Delhi, June 8: Pharma major Dr Reddys Laboratories Ltd today entered the Rs 100 crore dermatology topical steroid market with the launch of its new product 'UltravexTM' (Halobetasol).

Halobetasol is a potent steroid and has a higher efficacy associated with the product. Ultravex is currently available in a 10 gm pack and is used in the treatment of Psoriasis and Chronic Dermatoses.

The topical steroid market is the second most prescribed category by dermatologists with nearly 2.5 crore units sold every year, a statement said.

UNI